Delivery Order SPE2DB20D2014-SPE2DB26FA16Z
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,200.93 to supply BIKTARVY 50-200-25 mg tablets (30-count units) with delivery scheduled for October 23, 2025. This non-competitive, firm fixed-price delivery order was issued on October 22, 2025 and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $53,530.13 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of October 23, 2025. This non-set-aside competitive award was issued on October 22, 2025, to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $54,803.42 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of human...
- The Defense Logistics Agency awarded a delivery order valued at $7,882.67 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, was competitively awarded without set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency awarded a $36,289.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of July 22, 2025. This non-set-aside contract was competitively awarded on July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a brand-name antiretroviral medication used in HIV treatment, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $8,727.91 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency awarded a $15,696.60 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $25,916.48 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in HIV treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $88,600.01 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV, and this order fulfills...
- The Defense Logistics Agency awarded a $58,730.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 14, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of human...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA16ZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,420.56 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, underscoring the Defense Logistics Agency's role in supplying critical pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 10/23/25 |